Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
Launched by HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID · Dec 5, 2020
Trial Information
Current as of June 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at fractures that happen around implants or prosthetic joints in the upper and lower limbs, such as the shoulder, hip, and knee. These types of fractures can be complicated to treat and may lead to further health issues. The study, which is collecting data from over 70 hospitals in Spain, aims to find the best treatment options for each patient. By understanding how these fractures affect patients, doctors can improve care, reduce complications, and ultimately help patients recover better and faster.
To participate in this study, patients need to be at least 18 years old and have a diagnosed fracture around a prosthetic joint or implant in specific areas like the shoulder or hip. However, the study will not include patients with certain types of fractures, such as those related to cancer or during surgery. Participants can expect to contribute to important research that may lead to better treatment for others in the future, while also receiving care from experienced trauma surgeons and geriatricians.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with the diagnose of Periprosthetic fracture of the shoulder, elbow, hip or knee. Or patients with the diagnose of Peri-implant fracture of the scapula, humerus, forearm, pelvis, femur, patella, tibia or fibula. Or patient presenting cut-out or cut-in after DHS or nail after a proximal humeral fracture.
- • 18 years or older
- Exclusion Criteria:
- • Spine PP or PI fracture
- • PP or PI secondary to metastasis or tumoral fracture
- • PP or PI intraoperative fracture
- • PP or PI pathologic fracture
- • PP ankle fracture
- • PP or PI wrist or hand fracture
- • Fixation failure without any new fracture line: except cut-out or cut-in after DHS or nail of a proximal humeral fracture.
- • Pregnancy
About Hospital Clínico Universitario De Valladolid
The Hospital Clínico Universitario de Valladolid is a leading academic medical center in Spain, dedicated to advancing healthcare through innovative research and clinical trials. Affiliated with the University of Valladolid, the hospital combines cutting-edge medical practice with rigorous scientific inquiry, fostering a multidisciplinary approach to patient care and medical education. With a commitment to enhancing treatment outcomes and contributing to the global medical community, the hospital engages in a diverse array of clinical trials across various specialties, ensuring adherence to the highest ethical and regulatory standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Barcelona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Barcelona, , Spain
Gijón, , Spain
Valladolid, , Spain
Patients applied
Trial Officials
Héctor J Aguado, MD PhD
Study Director
Hospital Clínico Universitario Valladolid
Pablo Castillón, MD PhD
Study Director
Mútua Universitaria de Terrassa
Josep M Muñoz Vives, MD PhD
Principal Investigator
Althaia Xarxa Assistencial Universitària de Manresa
Cristina Ojeda-Thies, MD PhD
Principal Investigator
Hospital 12 de Octubre, Madrid
Pilar Camacho, MD PhD
Principal Investigator
Hospital Clinic of Barcelona
Jordi Teixidor, MD
Principal Investigator
Hospital Universitario Vall d´Hebrón
Pablo García-Portablella, MD
Principal Investigator
Hospital de Jove, Gijón
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials